Free Access
Issue |
Med Sci (Paris)
Volume 23, Number 4, Avril 2007
|
|
---|---|---|
Page(s) | 379 - 385 | |
Section | M/S revues | |
DOI | https://doi.org/10.1051/medsci/2007234379 | |
Published online | 15 April 2007 |
- Glenn GM, Kenney RT, Ellingsworth LR, et al. Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skin. Expert Rev Vaccines 2003; 2 : 253–67. [Google Scholar]
- Glenn GM, Rao M, Matyas GR, Alving CR. Skin immunization made possible by cholera toxin. Nature 1998; 391 : 851–3. [Google Scholar]
- Doherty TM, Andersen P. Vaccines for tuberculosis: novel concept and recent progress. Clin Microbiol Rev 2005; 18 : 687–702. [Google Scholar]
- Fine PEM, Rodrigues LC. Mycobacterial diseases. In : Moxon ER, ed. Modern vaccines : current practice and new approaches. A Lancet review. London : Edward Arnold, 1990 : 67–74. [Google Scholar]
- Girard MP, Fruth V, Kieny MP. A review of vaccine research and development: tuberculosis. Vaccine 2005; 23 : 5725–31. [Google Scholar]
- Henderson DA, Borio LL, Lane JM. Smallpox and vaccinia. In : Plotkin SA. Orenstein WA, eds. Vaccines, 4th ed. Philadelphia : Saunders, 2004 : 123–53. [Google Scholar]
- Poux JM, Ranger-Rogez S, Lagarde C, et al. Vaccination contre l’hépatite B : intérêt de l’administration intradermique chez les dialysés non-répondeurs par voie intramusculaire. Presse Med 1995; 34 : 803–6. [Google Scholar]
- Grosheide PM, Heijtink RA, De Knegt RJ, Schalm SW. Low dose hepatitis B vaccination in medical students: experience with the intradermal versus intramuscular route, and plasma versus recombinant vaccines. In : Coursaget P, Tong MJ, eds. Progress in hepatitis B immunization. Colloque Inserm, vol. 194. Paris : Inserm-John Libbey Eurotext, 1990 : 258. [Google Scholar]
- Denis F, Cogne M, Belec L. Femme enceinte et défense immunitaire antivirale. In : Denis F, ed. Les virus transmissibles de la mère à l’enfant. Paris : John Libbey Eurotext, 1999 : 24–56. [Google Scholar]
- Anjuère F, Czerkinsky C. Vaccination préventive et approches innovantesImmunité muqueuse et vaccination. Med Sci (Paris) 2007; 23 : 371–8. [Google Scholar]
- Phalipon A, Sansonetti P. La vaccination muqueuse cherche sa place parmi les nouvelles stratégies vaccinales. Med Sci (Paris) 2000; 16 : 905–11. [Google Scholar]
- Cui ZD, Tristram D, La Scolea LJ, et al. Induction of antibody response to Chlamydia trachomatis in the genital tract by oral immunization. Infect Immun 1991; 59 : 1465–9. [Google Scholar]
- Hill DR, Ford L, Lalloo DG. Oral cholera vaccines: use in clinical practice. Lancet 2006; 6 : 361–73. [Google Scholar]
- Delpeyroux F, Crainic R. L’éradication de la poliomyélite : un défi à l’aube du XXIe siècle. Virologie 1998; 2 (n° spécial) : 30–41. [Google Scholar]
- Desselberger V. Vaccins antirotavirus : développements et perspectives. Virologie 2005; 9 : 177–80. [Google Scholar]
- Pothier P, Agnello D. Les rotavirus et leur prévention. Spectra Biologie 2006; n° 150 : 23–7. [Google Scholar]
- Lee JS, Poo H, Han DP, et al. Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike proteins on Lactobacillus casei induces neutralizing antibodies in mice. J Virol 2006; 80 : 4079–87. [Google Scholar]
- Locht C. Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough. Plos Pathogens 2006; 2 : 7. [Google Scholar]
- Guiso N. Impact de la vaccination sur l’épidémiologie des maladies infectieuses : exemple de la coqueluche. Med Sci (Paris) 2007; 23 : 399–403. [Google Scholar]
- Belshe RB, Gruber WC, Mendelman PM, et al. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent intranasal influenza virus vaccine. J Infect Dis 2000; 181 : 1133–7. [Google Scholar]
- Belshe RB, Maassab HF, Mendelman PM. Influenza vaccine-live. In : Plotkin SA, Orenstein WA, eds. Vaccines, 4th ed. Philadelphia : Saunders, 2004 : 371–88. [Google Scholar]
- Denis F, Alain S, Hantz S, Lagrange P. Vaccination antivirale et immunité muqueuse respiratoire : un concept séduisant pour des résultats encore décevants. Presse Med 2005; 34 : 1245–53. [Google Scholar]
- De Castro JF, Bennett JV, Rincon HG, et al. Evaluation of immunogenicity and side effects of triple viral vaccine (MMR) in adults, given by two routes: subcutaneous and respiratory (aerosol). Vaccine 2005; 23 : 1079–84. [Google Scholar]
- Neutra MR, Kozlowski PA. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 2006; 6 : 148–58. [Google Scholar]
- Parez N, Fourgeux C, Mohamed A, et al. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection. J Virol 2006; 80 : 1752–61. [Google Scholar]
- Ogra PL, Faden H, Welliver RC. Vaccination strategies for mucosal immune responses. Clin Microbiol Rev 2001; 14 : 430–45. [Google Scholar]
- Ogra PL, Fishaut M, Gallagher MR. Viral vaccination via the mucosal routes. Rev Infect Dis 1980; 2 : 352–69. [Google Scholar]
- Glenn GM, Kenney RT. Mass vaccination: solutions in the skin. In : Plotkin SA, ed. Mass vaccination: global aspects-progressand obstacles. Berlin-Heidelberg : Springer-Verlag, 2006 : 247–68. [Google Scholar]
- World Health Reports. Fifty facts from the world health report 1998 : global health situation and trends. Geneva, Switzerland : World Health Organization, 1998 : 1955–2025. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.